Neonatal Abstinence Score

To assess the signs/severity of withdrawal in an infant

The Neonatal Abstinence Score is a standardized tool (most commonly the Finnegan system) that quantifies withdrawal severity in opioid‑exposed newborns to guide treatment initiation and monitoring 1 [Level III evidence].

Cry
Normal0Excessive, high-pitch less than 5 min+2Continuous, high-pitch more than 5 min+3
Sleep
Normal0Sleeps less than 3 hrs after feeding+1Sleeps less than 2 hrs after feeding+2Sleeps less than 1 hr after feeding+3
Moro Reflex
Normal0Hyperactive+2Markedly Hyperactive+3
Tremor
Normal0Mild when disturbed+1Mod-severe when disturbed+2Mild when undisturbed+3Mod-severe when undisturbed+4
Muscle tone
Normal0Increased+1
Excoriations
None or Normal0Yes; chin, knees, elbows, toes, nose+1
Myoclonic jerks
None0Yes+3
Generalized convulsions
None0Yes+5
Sweating
None or Normal0Yes; excessive+1
Hyperthermia
None or Normal037.2 - 38.3 C+138.4 C or higher+2
Frequent Yawning
None or Normal0More than 3 times per scoring interval+1
Mottling
None0Yes+1
Nasal stuffiness
No0Yes+1
Sneezing
None or Normal0More than 3 times per scoring interval+1
Nasal flaring
None0Yes+2
Respiratory rate
Normal0More than 60 times per minute+1Retractions and more than 60 times per minute+2
Excessive sucking
Normal0Yes+1
Poor feeding
Normal feeding0Infrequent, uncoordinated suck+2
Emesis
None or Normal02 or more times during or after feeding+2Projectile vomiting+3
Stool
Normal0Loose stools+2Watery stools+3

Indications for Use

Used to assess opioid‑exposed neonates with suspected withdrawal to determine severity, need for pharmacologic therapy, and response to treatment. Standard tools (e.g., Finnegan) predict treatment necessity (simplified version validated against full tool in 424 infants 1 [Level II evidence]). Guides timing/escalation of opioids and supports decisions on non‑pharmacologic care; alternative function‑based approaches (Eat‑Sleep‑Console) reduce treatment and length of stay in RCTs 2 [Level I evidence].

Insights & Cautions

Scores guide withdrawal treatment but remain subjective with limited psychometric reliability and high inter‑rater variability 1. High scores can occur in non–opioid conditions, vary with gestational age, and overestimate severity in preterm infants 2. Simplified versions correlate with full scales but still lack robust validation 3. Frequent scoring may trigger unnecessary pharmacologic therapy. Transitioning to functional assessment models (eat, sleep, console) reduces overtreatment without compromising safety 4.